Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease
Clinical trial NCT01187966 · COMPLETED
Trial details
- NCT number
- NCT01187966
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-10-01
- Enrollment
- 669
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.